Compound ID | 455
NB3353
Class: Beta-lactam; triclosan
| Agent Type: | Semisynthetic; Small molecule; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Unknown |
| Description: | NB2030 analogue; Li Q, Doppalapudi VR, Castillo R, et al. Analogs of NB2030, a Cephalosporin-triclosan conjugate, with reduced serum protein binding capacity. 43rd-ICAAC 2003;268 |
| Institute where first reported: | New Biotics (Kiadis Pharmaceuticals, Netherlands) |
| Year first mentioned: | 2003 |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.